| DOI: https://doi.org/10.14456/mujps.2017.4 | Pharm Sci Asia 2017; 44(1), 40-49 |
Cost of pneumonia in children: A systematic reviewV. Sirisuksan, Q.V. Trung, A. Riewpaiboon*
1 Division of Social and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand
2 Department of Pharmacy, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
3 Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy, Ho Chi Minh City 700000, Vietnam
Childhood pneumonia is a leading cause of mortality worldwide. The estimates of the economic burden of these illnesses will be beneficial to the design of effective treatment, management of resources, and evaluation of the cost-effectiveness of health interventions. Nevertheless, a systematic review of the economic cost of treatment of pneumonia in children has not been performed. Thus, the objective of this study was to systematically review the cost of pneumonia in children. A systematic literature search was conducted in PubMed, including journal articles reporting the cost of pneumonia in children from 2000 to 2015. Seventeen articles were selected for the review. Ten articles included only direct medical cost. One article included direct medical cost and direct non-medical cost. Six articles included all components, i.e., direct medical cost, direct non-medical cost and indirect cost. Costs were converted to 2015 US dollars. The results show a wide range of cost estimates due to study design, types of pneumonia, patient age, patient types (inpatient or outpatient), and the economic and healthcare systems in each country. Pneumonia has a substantial economic impact, and the lack of information on the cost of pneumonia in several countries highlights the need for further work in order to describe the global economic burden of pneumonia.
Keyword:
cost of illness, children, pneumonia, systematic review, review
Download full paper (PDF File size: 414.44 KB.)
|
